Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

RIBE BIOGAS A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.3% 0.3%   Bankruptcy risk   0.5% 0.5% 0.5% 0.5% 0.4% 1.2% 5.2% 5.2%   Credit score (0-100)   99 99 99 99 99 80 43 43   Credit rating   AAA AAA AAA AAA AAA A BBB BBB   Credit limit (kDKK)   4,314.6 5,340.1 7,175.0 12,142.2 7,236.5 4,009.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   22,448 25,006 35,485 59,254 35,127 114,943 0.0 0.0   EBITDA   11,022 14,140 22,723 45,211 21,093 98,578 0.0 0.0   EBIT   11,022 14,140 22,723 45,211 21,093 98,578 0.0 0.0   Pre-tax profit (PTP)   9,454.6 12,290.4 21,266.2 43,780.9 19,239.1 96,468.4 0.0 0.0   Net earnings   7,374.7 9,577.5 16,570.7 34,148.3 14,929.2 75,223.5 0.0 0.0   Pre-tax profit without non-rec. items   9,455 12,290 21,266 43,781 19,239 96,468 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   78,105 92,051 90,450 89,952 95,842 119,964 0.0 0.0   Shareholders equity total   33,883 40,461 52,032 76,180 56,109 101,333 50,333 50,333   Interest-bearing liabilities   46,698 53,471 45,171 42,214 37,117 33,525 0.0 0.0   Balance sheet total (assets)   90,710 105,320 111,372 145,078 115,998 162,207 50,333 50,333   Net Debt   45,858 49,026 38,284 11,571 36,409 20,956 -50,086 -50,086     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   22,448 25,006 35,485 59,254 35,127 114,943 0.0 0.0   Gross profit growth   -21.4% 11.4% 41.9% 67.0% -40.7% 227.2% -100.0% 0.0%   Employees   11 12 14 12 12 13 0 0   Employee growth %   0.0% 9.1% 16.7% -14.3% 0.0% 8.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   90,710 105,320 111,372 145,078 115,998 162,207 50,333 50,333   Balance sheet change%   35.9% 16.1% 5.7% 30.3% -20.0% 39.8% -69.0% 0.0%   Added value   11,021.7 14,139.7 22,722.5 45,211.4 21,092.8 98,577.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   17,926 13,946 -1,596 -183 5,854 24,086 -119,964 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   49.1% 56.5% 64.0% 76.3% 60.0% 85.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   14.0% 14.4% 21.0% 35.3% 16.2% 70.9% 0.0% 0.0%   ROI %   15.4% 15.9% 23.2% 40.2% 18.7% 81.6% 0.0% 0.0%   ROE %   23.8% 25.8% 35.8% 53.3% 22.6% 95.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   37.4% 38.4% 46.7% 52.5% 48.4% 62.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   416.1% 346.7% 168.5% 25.6% 172.6% 21.3% 0.0% 0.0%   Gearing %   137.8% 132.2% 86.8% 55.4% 66.2% 33.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.9% 3.7% 3.0% 3.3% 4.7% 6.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.7 0.6 0.8 2.0 0.8 1.5 0.0 0.0   Current Ratio   0.7 0.6 0.8 2.0 0.8 1.5 0.0 0.0   Cash and cash equivalent   840.2 4,445.2 6,886.8 30,642.4 708.2 12,568.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -4,542.4 -7,496.9 -5,302.9 27,545.7 -3,625.0 13,805.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   1,002 1,178 1,623 3,768 1,758 7,583 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1,002 1,178 1,623 3,768 1,758 7,583 0 0   EBIT / employee   1,002 1,178 1,623 3,768 1,758 7,583 0 0   Net earnings / employee   670 798 1,184 2,846 1,244 5,786 0 0